Diseases

Prevalence

5581.4 / 100K

Incidence

918.7 / 100K/yr

218 drugs in development·147 companies·1 clinical trial

Drug Pipeline by Phase

Approved(33)

Drug	Company
adcirca	ELI LILLY & Co (LLY)
Alginic Sodium Diester Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
Alinity® family	ABBOTT LABORATORIES (ABT)
ambrisentan	Mylan II B.V. (MYL)
baclofen	ANI PHARMACEUTICALS INC (ANIP)
baclofen	Impax Laboratories, LLC (IPXL)
BinaxNOW®	ABBOTT LABORATORIES (ABT)
BinaxNOW® / Panbio® rapid testing platforms	ABBOTT LABORATORIES (ABT)
Bumetanide for Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
cerebroprotein hydroloysate	CHINA PHARMA HOLDINGS, INC. (CPHI)
Cerebroprotein Hydroloysate Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
CerebroproteinHydroloysate Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
cutaquig	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
cuvitru	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
epoprostenol	Mylan II B.V. (MYL)
erythromycin lactobionate	NEXUS BIOPHARMA INC (NEXS)
gammagard liquid	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
Ge Hong Beriberi Water	China Health Industries Holdings, Inc. (CHHE)
hizentra	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
nintedanib	DR REDDYS LABORATORIES LTD (RDY)
nintedanib	NYMOX PHARMACEUTICAL CORP (NYMXF)
nintedanib	Aptinyx Inc. (APTX)
nintedanib	EXELIXIS, INC. (EXEL)
nintedanib	X4 Pharmaceuticals, Inc (XFOR)
nu.q nets	VOLITIONRX LTD (VNRX)
prednisone	DR REDDYS LABORATORIES LTD (RDY)
theophylline	Amneal Pharmaceuticals, Inc. (AMRX)
tobramycin	Amneal Pharmaceuticals, Inc. (AMRX)
treprostinil	Teva Pharmaceutical Industries Limited (TEVA)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
vispa-cel based on fda interactions to date	Caribou Biosciences, Inc. (CRBU)
xembify	KORU Medical Systems Inc. Common Stock (DE) (KRMD)

Phase 3(21)

Drug	Company
[14c]azd0780	ASTRAZENECA PLC (AZN)
[14c]azd0780 solution for infusion	ASTRAZENECA PLC (AZN)
acellular tissue engineered vessel	Humacyte Inc. (HUMA)
atrasentan	CHINOOK THERAPEUTICS, INC. (KDNY)
bexobrutideg	Nurix Therapeutics, Inc. (NRIX)
bms-986515	Juno Therapeutics, Inc. (JUNO)
etavopivat	Novo Nordisk A/S (NVO)
immune globulin	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
imu-381	IMMUNIC, INC. (IMUX)
latozinemab	Alector, Inc. (ALEC)
Nerandomilast	Valneva SE (VALN)
posoleucel	Kalaris Therapeutics, Inc. (KLRS)
Standard Medical Therapy	Merus N.V. (MRUS)
tak-771	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-771	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-881	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-881	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-881	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Vatiquinone	PTC THERAPEUTICS, INC. (PTCT)
zigakibart	Novartis AG (NVS)
zigakibart	Novartis AG (NVS)

Phase 2(34)

Drug	Company
ADX-631	Aldeyra Therapeutics, Inc. (ALDX)
AKB-097	Akebia Therapeutics, Inc. (AKBA)
akcea-angptl3-lrx	AKCEA THERAPEUTICS, INC. (AKCA)
amx0318	Amylyx Pharmaceuticals, Inc. (AMLX)
ARV-102	ARVINAS, INC. (ARVN)
ATI-052	Aclaris Therapeutics, Inc. (ACRS)
azelaprag	BioAge Labs, Inc. (BIOA)
cenplacel-l	Celularity Inc. (CELU)
dfv890	Novartis AG (NVS)
dfv890	Novartis AG (NVS)
disc-0974	Disc Medicine, Inc. (IRON)
etokimab	ANAPTYSBIO, INC (ANAB)
IGM-2644	IGM Biosciences, Inc. (IGMS)
imvotamab	IGM Biosciences, Inc. (IGMS)
kds2010	SCILEX HOLDING CO (SCLX)
kio-101	Kiora Pharmaceuticals Inc. (KPRX)
KPI-014	KALA BIO, Inc. (KALA)
KT-474/SAR444656	Kymera Therapeutics, Inc. (KYMR)
Lesigercept	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
MORF-057	ELI LILLY & Co (LLY)
napazimone	DBV Technologies S.A. (DBVT)
olipudase alfa	Sanofi (SNY)
pl8177	PALATIN TECHNOLOGIES INC (PTN)
prt2761	PORTOLA PHARMACEUTICALS INC (PTLA)
renal autologous cell therapy	PROKIDNEY CORP. (PROK)
rencofilstat (formerly CRV431)	Hepion Pharmaceuticals, Inc. (CTRVP)
rist4721	ARENA PHARMACEUTICALS INC (ARNA)
sepranolone	RELMADA THERAPEUTICS, INC. (RLMD)
sln360	Silence Therapeutics Plc (SLN)
tour006	Tourmaline Bio, Inc. (TRML)
tour006 -	Tourmaline Bio, Inc. (TRML)
Triamcinolone Hexacetonide Inj Susp 20 MG/ML	Revance Therapeutics, Inc. (RVNC)
tti-109	Tvardi Therapeutics, Inc. (TVRD)
zaltenibart	OMEROS CORP (OMER)

Phase 1(33)

Drug	Company
ach-5228	ACHILLION PHARMACEUTICALS INC (ACHN)
alvr106	Kalaris Therapeutics, Inc. (KLRS)
amt-126	Applied Molecular Transport Inc. (AMTI)
ANB101	ANAPTYSBIO, INC (ANAB)
anito-cel	Arcellx, Inc. (ACLX)
AUR200	Aurinia Pharmaceuticals Inc. (AUPH)
BG-A3004	BeOne Medicines Ltd. (ONC)
BIVV003	SANGAMO THERAPEUTICS, INC (SGMO)
BP1001-A	BIO-PATH HOLDINGS, INC. (BPTH)
CUE-401	Cue Biopharma, Inc. (CUE)
DVX201 (Unmodified Natural Killer Cells)	Coeptis Therapeutics Holdings Inc. (COEP)
frtx-02	Fresh Tracks Therapeutics, Inc. (FRTX)
ft839	FATE THERAPEUTICS INC (FATE)
hyqvia	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
hyqvia	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
KER-065	Keros Therapeutics, Inc. (KROS)
KYV-101	Filana Therapeutics Inc. (FLNA)
LUCAR-G79 T cells	Legend Biotech Corp (LEGN)
m230	MOMENTA PHARMACEUTICALS INC (MNTA)
mb-106	MUSTANG BIO, INC. (MBIO)
mipomersen	TG THERAPEUTICS, INC. (TGTX)
nnc0560-0004	Novo Nordisk A/S (NVO)
ov350	Ovid Therapeutics Inc. (OVID)
prn2246/sar442168	Principia Biopharma Inc. (PRNB)
PRX019	PROTHENA CORP PUBLIC LTD CO (PRTA)
rlyb114	Rallybio Corp (RLYB)
rlyb116	Rallybio Corp (RLYB)
SRK-373	Scholar Rock Holding Corp (SRRK)
Standard Lymphodepletion regimen	Arcellx, Inc. (ACLX)
tocilizumab	Juno Therapeutics, Inc. (JUNO)
velinotamig	Cullinan Therapeutics, Inc. (CGEM)
vib7734	Viela Bio, Inc. (VIE)
wtx-921	Werewolf Therapeutics, Inc. (HOWL)

Preclinical(72)

Drug	Company
a2342	ALBIREO PHARMA, INC. (ALBO)
a2a agonists	REBUS HOLDINGS, INC. (NSPX)
ach-5548	ACHILLION PHARMACEUTICALS INC (ACHN)
acu-6151	KUBOTA PHARMACEUTICAL HOLDINGS CO LTD (ACUC)
adi-100	Aditxt, Inc. (ADTX)
ADX-743	Aldeyra Therapeutics, Inc. (ALDX)
ALPHA-0702	Alpha Cognition Inc. (ACOG)
ALPHA-0802	Alpha Cognition Inc. (ACOG)
ar-14034 sr	AERIE PHARMACEUTICALS INC (AERI)
ATYR0101	aTYR PHARMA INC (ATYR)
ATYR0750	aTYR PHARMA INC (ATYR)
Base editing therapies (C3 and complement targets)	Apellis Pharmaceuticals, Inc. (APLS)
cb5138-3	COHBAR, INC. (COBU)
cnm-agzn17	Clene Inc. (CLNN)
CPI-182	Corvus Pharmaceuticals, Inc. (CRVS)
crebankitug	Zura Bio Ltd (ZURA)
cts-2090	Histogen Inc. (HSTO)
cts-2096	Histogen Inc. (HSTO)
dolcanatide	SYNERGY PHARMACEUTICALS LLC (SGYP)
eb07	Edesa Biotech, Inc. (EDSA)
EPS-3903	ENANTA PHARMACEUTICALS INC (ENTA)
eq504	Equillium, Inc. (EQ)
frtx-10	Fresh Tracks Therapeutics, Inc. (FRTX)
hpp3033	vTv Therapeutics Inc. (VTVT)
ht-003	Hoth Therapeutics, Inc. (HOTH)
ht-alz	Hoth Therapeutics, Inc. (HOTH)
ht-va	Hoth Therapeutics, Inc. (HOTH)
ic-500	IVERIC bio, Inc. (ISEE)
idrx-73	Blueprint Medicines Corp (BPMC)
inb-600	IN8BIO, INC. (INAB)
inb-619	IN8BIO, INC. (INAB)
IRF5 program	ALUMIS INC. (ALMS)
kros 102	Kairos Pharma, LTD. (KAPA)
KT-295	Kymera Therapeutics, Inc. (KYMR)
KYV-201	Intellia Therapeutics, Inc. (NTLA)
lb-1	ProPhase Labs, Inc. (PRPH)
lb-2	ProPhase Labs, Inc. (PRPH)
lnc-001	REBUS HOLDINGS, INC. (NSPX)
man-11	Q BioMed Inc. (QBIO)
man-19	Q BioMed Inc. (QBIO)
man-dex	NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)
mupadolimab	Corvus Pharmaceuticals, Inc. (CRVS)
nexi-004	NexImmune, Inc. (NEXI)
next-generation ITK inhibitor preclinical candidates	Corvus Pharmaceuticals, Inc. (CRVS)
niagen	Niagen Bioscience, Inc. (NAGE)
Np-01	CNBX Pharmaceuticals Inc. (CNBX)
NP-02	CNBX Pharmaceuticals Inc. (CNBX)
oc-101	Oyster Point Pharma, Inc. (OYST)
optejet ufd	HYPERION DEFI, INC. (HYPD)
Oral complement inhibitor	Apellis Pharmaceuticals, Inc. (APLS)
oral factor d inhibitors	ACHILLION PHARMACEUTICALS INC (ACHN)
oral small molecule c5 inhibitor	RA PHARMACEUTICALS, INC. (RARX)
phoenix auto	Phoenix Life Sciences International Limited. (PLSI)
pl7737	PALATIN TECHNOLOGIES INC (PTN)
prime edited scip	Prime Medicine, Inc. (PRME)
prx-119	Protalix BioTherapeutics, Inc. (PLX)
pt001	Pandion Therapeutics, Inc. (PAND)
repurposed drug for cns cancer	Cosmos Health Inc. (COSM)
rlyb332	Rallybio Corp (RLYB)
sc379	Sana Biotechnology, Inc. (SANA)
sequential-dialysis technique	PREMIER BIOMEDICAL INC (BIEI)
sg293	Sana Biotechnology, Inc. (SANA)
sg299	Sana Biotechnology, Inc. (SANA)
sl65-based candidates	LogicBio Therapeutics, Inc. (LOGC)
sln548	Silence Therapeutics Plc (SLN)
szn-413	Surrozen Inc. (SRZN)
tmb-003	TREX WIND-DOWN, INC. (TMBR)
torudokimab	Zura Bio Ltd (ZURA)
undisclosed cardiometabolic program 1	Korro Bio, Inc. (KRRO)
undisclosed cardiometabolic program 2	Korro Bio, Inc. (KRRO)
vib1116	Viela Bio, Inc. (VIE)
zofin	Zeo ScientifiX, Inc. (ZEOX)

Unknown(12)

Drug	Company
BCX10013	BIOCRYST PHARMACEUTICALS INC (BCRX)
BinaxNOW® and Panbio® rapid testing platforms	ABBOTT LABORATORIES (ABT)
Cannabis Genomic Study (Sangre AT, LLC)	WEED, INC. (BUDZ)
infectimune	PDS Biotechnology Corp (PDSB)
InFoods® platform (other disease targets)	BIOMERICA INC (BMRA)
Next generation bispecific antibody platform	Celldex Therapeutics, Inc. (CLDX)
Oral C2 Inhibitor	BIOCRYST PHARMACEUTICALS INC (BCRX)
Oral C5 Inhibitor	BIOCRYST PHARMACEUTICALS INC (BCRX)
ProLectin-Rx	BIOXYTRAN, INC (BIXT)
Remicade	Merck & Co., Inc. (MRK)
Simponi	Merck & Co., Inc. (MRK)
ST-400	SANGAMO THERAPEUTICS, INC (SGMO)

Early Phase 1(2)

Drug	Company
LCAR-AIO T cells	Legend Biotech Corp (LEGN)
LUCAR-DKS1 NK cells	Legend Biotech Corp (LEGN)

Phase 1/Phase 2(6)

Drug	Company
aav9-glb1	National Research Corporation Common Stock (Delaware) (NRC)
axo-aav-gm2	Sio Gene Therapies Inc. (SIOX)
miransertib	ARQULE INC (ARQL)
syn-020	Theriva Biologics, Inc. (TOVX)
tb-500	IO Biotech, Inc. (IOBT)
XmAb564	Xencor Inc (XNCR)

Phase 4(5)

Drug	Company
Akkermansia muciniphila + Infliximab	ENANTA PHARMACEUTICALS INC (ENTA)
Dexmedetomidine infusion	COGNITION THERAPEUTICS INC (CGTX)
empagliflozin	ENANTA PHARMACEUTICALS INC (ENTA)
immune globulin	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Infliximab	ENANTA PHARMACEUTICALS INC (ENTA)

Compare drugs

adcirca vs Alginic Sodium Diester Injection adcirca vs Alinity® family adcirca vs ambrisentan

Frequently asked questions

How many drugs are in development for Diseases?

BioSniper tracks 218 drugs in development for Diseases across 147 companies.

How many clinical trials target Diseases?

There are 1 clinical trial targeting Diseases tracked by BioSniper.

What is the prevalence of Diseases?

The estimated prevalence of Diseases is approximately 5581.4 per 100,000 population.

Deep-dive into Diseases

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis